Page last updated: 2024-09-03

cp 65,526 and Lung Neoplasms

cp 65,526 has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ambudkar, SV; Bahr, JC; Bates, SE; Di Pietro, A; Macalou, S; Obrzut, T; Polgar, O; Robey, RW; Shukla, S	1

Other Studies

1 other study(ies) available for cp 65,526 and Lung Neoplasms

Article	Year
Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells. Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:3 Topics: Adenosine Triphosphatases; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Azides; Biological Transport; Carbazoles; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescence; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Immunoblotting; Iodine Radioisotopes; Lung Neoplasms; Neoplasm Proteins; Prazosin	2009

Article

Year

Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells.

Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:3

Topics: Adenosine Triphosphatases; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Azides; Biological Transport; Carbazoles; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescence; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Immunoblotting; Iodine Radioisotopes; Lung Neoplasms; Neoplasm Proteins; Prazosin

2009